Literature DB >> 26292176

Association of Thyroid Nodule Size and Bethesda Class With Rate of Malignant Disease.

Marcus J Magister1, Irina Chaikhoutdinov1, Eric Schaefer2, Nicole Williams3, Brian Saunders1, David Goldenberg1.   

Abstract

IMPORTANCE: The ability to accurately stratify patients with thyroid nodules (TNs) preoperatively is imperative because most TNs are benign. The reliability of fine-needle aspiration biopsy (FNAB) in large TNs has been questioned in recent literature.
OBJECTIVE: To determine whether TN size affects the reliability of FNAB results, and to determine the rates of malignant disease of each Bethesda class at Penn State Medical Center. DESIGN, SETTING, AND PARTICIPANTS: Retrospective electronic medical record review of patients undergoing FNAB followed by thyroidectomy from March 2010 through December 2013 at an academic, tertiary referral center. A total of 297 patients with 326 TNs were identified as part of a consecutive series. MAIN OUTCOMES AND MEASURES: The primary outcome was to determine the rate of malignant disease of TNs smaller than 3.0 cm or 3.0 cm or larger and of each Bethesda class. Statistical analysis included χ(2) tests. The secondary outcome was to develop logistic regression models to estimate the probability of malignant disease on final pathologic diagnosis as predicted by TN size as well as TN size in conjunction with Bethesda class.
RESULTS: Of the 297 patients, 233 were female (78.4%). The mean (SD) age was 51.0 (15.4) years. Of the 326 TNs, 143 were malignant on surgical histopathologic analysis (43.7%). The mean TN size was 2.0 (1.4) cm. Rates of malignant disease for Bethesda classes 1 to 6 were 0% (95% CI, 0%-26.0%), 6.0% (95% CI, 1.7%-14.6%), 30.2% (95% CI, 18.3%-44.3%), 23.5% (95% CI, 14.8%-34.2%), 72.4% (95% CI, 52.8%-87.3%), and 98.8% (95% CI, 93.5%-99.9%), respectively. Overall sensitivity and specificity (excluding class 1 TNs) were 97.2% and 36.8%, respectively. The false-negative rate of benign cytologic results was 6.0% (95% CI, 1.7%-14.6%); only 1 false-negative result occurred in TNs 3.0 cm or greater. Of the TNs smaller than 3.0 cm, 48.4% were malignant compared with 33.3% of TNs 3.0 cm or greater (P = .049). Both Bethesda class and TN size were significant variables (P < .05) within our logistic regression models indicating that higher Bethesda class and TN size smaller than about 2.0 cm were associated with increased probabilities of malignant disease. CONCLUSIONS AND RELEVANCE: Our results suggest that smaller TNs (smaller than about 2.0 cm) are associated with increased probabilities of malignant disease irrespective of Bethesda class. Routine diagnostic thyroid lobectomy solely owing to TN size of 3.0 cm or greater need not be performed.

Entities:  

Mesh:

Year:  2015        PMID: 26292176     DOI: 10.1001/jamaoto.2015.1451

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  7 in total

1.  Association between thyroid nodule size and malignancy rate.

Authors:  M Jinih; F Faisal; K Abdalla; M Majeed; A A Achakzai; C Heffron; J McCarthy; H P Redmond
Journal:  Ann R Coll Surg Engl       Date:  2019-12-23       Impact factor: 1.891

2.  Clinical and Ultrasound Thyroid Nodule Characteristics and Their Association with Cytological and Histopathological Outcomes: A Retrospective Multicenter Study in High-Resolution Thyroid Nodule Clinics.

Authors:  María Molina-Vega; Carlos Antonio Rodríguez-Pérez; Ana Isabel Álvarez-Mancha; Gloria Baena-Nieto; María Riestra; Victoria Alcázar; Ana Reyes Romero-Lluch; Juan C Galofré; José C Fernández-García
Journal:  J Clin Med       Date:  2019-12-09       Impact factor: 4.241

Review 3.  2021 Korean Thyroid Imaging Reporting and Data System and Imaging-Based Management of Thyroid Nodules: Korean Society of Thyroid Radiology Consensus Statement and Recommendations.

Authors:  Eun Ju Ha; Sae Rom Chung; Dong Gyu Na; Hye Shin Ahn; Jin Chung; Ji Ye Lee; Jeong Seon Park; Roh-Eul Yoo; Jung Hwan Baek; Sun Mi Baek; Seong Whi Cho; Yoon Jung Choi; Soo Yeon Hahn; So Lyung Jung; Ji-Hoon Kim; Seul Kee Kim; Soo Jin Kim; Chang Yoon Lee; Ho Kyu Lee; Jeong Hyun Lee; Young Hen Lee; Hyun Kyung Lim; Jung Hee Shin; Jung Suk Sim; Jin Young Sung; Jung Hyun Yoon; Miyoung Choi
Journal:  Korean J Radiol       Date:  2021-10-26       Impact factor: 3.500

4.  Navigating the Debate on Managing Large (≥4 cm) Thyroid Nodules.

Authors:  Samantha N Steinmetz-Wood; Amanda G Kennedy; Bradley J Tompkins; Matthew P Gilbert
Journal:  Int J Endocrinol       Date:  2022-04-16       Impact factor: 2.803

5.  Risk of Malignancy in Thyroid Nodules 4 cm or Larger.

Authors:  Uchechukwu C Megwalu
Journal:  Endocrinol Metab (Seoul)       Date:  2017-02-06

6.  Impact of Nodule Size on Malignancy Risk Differs according to the Ultrasonography Pattern of Thyroid Nodules.

Authors:  Min Ji Hong; Dong Gyu Na; Jung Hwan Baek; Jin Yong Sung; Ji-Hoon Kim
Journal:  Korean J Radiol       Date:  2018-04-06       Impact factor: 3.500

7.  2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology.

Authors:  Ji-Hoon Kim; Jung Hwan Baek; Hyun Kyung Lim; Hye Shin Ahn; Seon Mi Baek; Yoon Jung Choi; Young Jun Choi; Sae Rom Chung; Eun Ju Ha; Soo Yeon Hahn; So Lyung Jung; Dae Sik Kim; Soo Jin Kim; Yeo Koon Kim; Chang Yoon Lee; Jeong Hyun Lee; Kwang Hwi Lee; Young Hen Lee; Jeong Seon Park; Hyesun Park; Jung Hee Shin; Chong Hyun Suh; Jin Yong Sung; Jung Suk Sim; Inyoung Youn; Miyoung Choi; Dong Gyu Na
Journal:  Korean J Radiol       Date:  2018-06-14       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.